Company Name: TRACON Pharmaceuticals, Inc.   

TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of therapies designed to treat age-related macular degeneration (AMD), cancer and fibrotic diseases.

Ticker Symbol: TCON (NASDAQ)

Company Website: www.traconpharma.com

Headquarters: San Diego, CA